Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 363

Related Citations for PubMed (Select 20087643)

1.

A bupropion smoking cessation clinical trial for cancer patients.

Schnoll RA, Martinez E, Tatum KL, Weber DM, Kuzla N, Glass M, Ridge JA, Langer C, Miyamoto C, Wileyto EP, Leone F.

Cancer Causes Control. 2010 Jun;21(6):811-20. doi: 10.1007/s10552-010-9507-8. Epub 2010 Jan 20.

PMID:
20087643
2.

A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.

Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.

J Clin Psychopharmacol. 2007 Aug;27(4):380-6.

PMID:
17632223
3.

Outcomes from an outpatient smoking-cessation clinic.

Roth MT, Andrus MR, Westman EC.

Pharmacotherapy. 2005 Feb;25(2):279-88.

PMID:
15767242
4.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
5.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
6.

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB.

N Engl J Med. 1999 Mar 4;340(9):685-91.

7.

A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia.

George TP, Vessicchio JC, Sacco KA, Weinberger AH, Dudas MM, Allen TM, Creeden CL, Potenza MN, Feingold A, Jatlow PI.

Biol Psychiatry. 2008 Jun 1;63(11):1092-6. Epub 2007 Dec 21.

8.

Bupropion for smoking cessation: a randomized trial.

Simon JA, Duncan C, Carmody TP, Hudes ES.

Arch Intern Med. 2004 Sep 13;164(16):1797-803.

PMID:
15364675
9.

A comparison of sustained-release bupropion and placebo for smoking cessation.

Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM.

N Engl J Med. 1997 Oct 23;337(17):1195-202.

10.
11.

A placebo controlled trial of bupropion for smoking cessation in schizophrenia.

George TP, Vessicchio JC, Termine A, Bregartner TA, Feingold A, Rounsaville BJ, Kosten TR.

Biol Psychiatry. 2002 Jul 1;52(1):53-61.

PMID:
12079730
13.

Interventions for smoking cessation and reduction in individuals with schizophrenia.

Tsoi DT, Porwal M, Webster AC.

Cochrane Database Syst Rev. 2013 Feb 28;2:CD007253. doi: 10.1002/14651858.CD007253.pub3. Review.

PMID:
23450574
14.

A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.

T√łnnesen P, Tonstad S, Hjalmarson A, Lebargy F, Van Spiegel PI, Hider A, Sweet R, Townsend J.

J Intern Med. 2003 Aug;254(2):184-92.

PMID:
12859700
15.

A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.

Evins AE, Culhane MA, Alpert JE, Pava J, Liese BS, Farabaugh A, Fava M.

J Clin Psychopharmacol. 2008 Dec;28(6):660-6. doi: 10.1097/JCP.0b013e31818ad7d6.

16.
17.

A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain.

Rigotti NA, Gonzales D, Dale LC, Lawrence D, Chang Y; CIRRUS Study Group.

Addiction. 2009 Feb;104(2):266-76. doi: 10.1111/j.1360-0443.2008.02454.x.

PMID:
19149823
18.

Interventions for smoking cessation and reduction in individuals with schizophrenia.

Tsoi DT, Porwal M, Webster AC.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD007253. doi: 10.1002/14651858.CD007253.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;2:CD007253.

PMID:
20556777
19.

Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.

Simon JA, Duncan C, Huggins J, Solkowitz S, Carmody TP.

Nicotine Tob Res. 2009 Jun;11(6):663-9. doi: 10.1093/ntr/ntp047. Epub 2009 Apr 24.

PMID:
19395688
20.

The effect of bupropion on nicotine craving and withdrawal.

Shiffman S, Johnston JA, Khayrallah M, Elash CA, Gwaltney CJ, Paty JA, Gnys M, Evoniuk G, DeVeaugh-Geiss J.

Psychopharmacology (Berl). 2000 Jan;148(1):33-40.

PMID:
10663415
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk